rethinkTHC Search
Menu
Study breakdown

Systematic review of CBD for mental health conditions found mixed but promising signals

Systematic ReviewModerate evidence
The takeaway

A systematic review of 23 studies found preliminary evidence that CBD may help with anxiety, psychosis, and substance use disorders, but evidence for depression and PTSD remains limited.

Mental health clinicians, CBD consumers, and researchers studying cannabinoid therapeutics.

23 studies reviewed across anxiety, psychosis, depression, PTSD, and substance use

What the researchers found

Across 23 included studies, CBD showed the most consistent positive signals for anxiety disorders and as an adjunct treatment for schizophrenia. Evidence for depression, PTSD, and sleep disorders was more limited and inconsistent. Most studies were small and used varied dosing protocols.

Why it matters

CBD products are widely marketed for mental health, but the evidence base is still developing. This review provides a structured assessment of where the science actually stands across different conditions.

The numbers in context

23 studies included; conditions covered: anxiety, schizophrenia, depression, PTSD, substance use disorders, and sleep. CBD doses ranged widely across studies.

How the study worked

Systematic review following PRISMA guidelines, searching multiple databases. Included 23 studies (RCTs, open-label trials, case series) examining CBD for various mental health conditions.

What this study cannot tell us

High heterogeneity in study designs, doses, and populations. Most included studies were small. Publication bias may favor positive results. Rapid pace of new research means the review may not capture the latest findings.

How to read the evidence

Moderate: systematic review methodology but limited by small, heterogeneous included studies.

When this study was published

Published 2020.

The bigger picture

The gap between CBD marketing claims and scientific evidence remains wide. While some conditions show genuine promise (particularly anxiety and psychosis), others lack sufficient evidence. This review helps distinguish hype from substance.

Questions still open

  • What are the optimal CBD doses for specific mental health conditions? Will larger, well-designed RCTs confirm the promising signals seen in smaller studies?

Common questions

Which mental health conditions had the best evidence for CBD?
Anxiety disorders and schizophrenia (as adjunct treatment) showed the most consistent positive signals. Evidence for depression, PTSD, and sleep was more limited.
Is CBD proven to treat mental health conditions?
Not yet. The review found promising preliminary signals, particularly for anxiety and psychosis, but most studies were small and used different protocols. Larger trials are needed.

Read the original research

The therapeutic role of Cannabidiol in mental health: a systematic review.

Journal of cannabis research, 2(1), 2

Citation

Khan, Rabia; Naveed, Sadiq; Mian, Nadeem; Fida, Ania; Raafey, Muhammad Abdur; Aedma, Kapil Kiran. (2020). The therapeutic role of Cannabidiol in mental health: a systematic review.. Journal of cannabis research, 2(1), 2. https://doi.org/10.1186/s42238-019-0012-y

Explore the wider topic